Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and acceptability of methylphenidate for gait disorders in Parkinson's disease
2008-005801-20Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) and Gait disorder comparing Methylphenidate with Placebo (2 arms). Primary endpoint: Stand-Walk-Sit test time. Started Mar 2009; status: completed.
02
Drugs
methylphenidate
03
Conditions
Parkinson's disease (PD)Gait disorder
Beyond the preview
Go deeper on 2008-005801-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005801-20.